Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2000 1
2003 4
2005 1
2006 1
2007 1
2010 2
2012 3
2013 5
2014 2
2015 1
2016 3
2017 2
2018 1
2019 4
2020 1
2021 4
2022 4
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Repurposing chemotherapy-induced peripheral neuropathy grading.
Velasco R, Argyriou AA, Cornblath DR, Bruna P, Alberti P, Rossi E, Merkies ISJ, Psimaras D, Briani C, Lalisang RI, Schenone A, Cavaletti G, Bruna J; CI‐PeriNomS Group. Velasco R, et al. Eur J Neurol. 2024 Dec;31(12):e16457. doi: 10.1111/ene.16457. Epub 2024 Sep 16. Eur J Neurol. 2024. PMID: 39282967 Free PMC article.
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.
Koudriavtseva T, Lorenzano S, Cellerino M, Truglio M, Fiorelli M, Lapucci C, D'Agosto G, Conti L, Stefanile A, Zannino S, Filippi MM, Cortese A, Piantadosi C, Maschio M, Maialetti A, Galiè E, Salvetti M, Inglese M. Koudriavtseva T, et al. Among authors: galie e. Front Immunol. 2023 Jul 31;14:1226616. doi: 10.3389/fimmu.2023.1226616. eCollection 2023. Front Immunol. 2023. PMID: 37583699 Free PMC article.
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity.
Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Alberti P, Bruna J, Argyriou AA, Briani C, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Faber CG, Lalisang RI, Brandsma D, Koeppen S, Kerrigan S, Schenone A, Grisold W, Mazzeo A, Padua L, Dorsey SG, Penas-Prado M, Valsecchi MG; CI-PeriNomS Group. Cavaletti G, et al. J Peripher Nerv Syst. 2019 Mar;24(1):111-119. doi: 10.1111/jns.12306. Epub 2019 Feb 8. J Peripher Nerv Syst. 2019. PMID: 30672664
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience.
Diamanti L, Picca A, Bini P, Gastaldi M, Alfonsi E, Pichiecchio A, Rota E, Rudà R, Bruno F, Villani V, Galiè E, Vogrig A, Valente M, Zoccarato M, Poretto V, Giometto B, Cimminiello C, Del Vecchio M, Marchioni E. Diamanti L, et al. Among authors: galie e. Neurol Sci. 2022 Mar;43(3):2031-2041. doi: 10.1007/s10072-021-05561-z. Epub 2021 Aug 23. Neurol Sci. 2022. PMID: 34424427 Free article.
39 results